InsidersTradesSigma
Track the MAYNE PHARMA GROUP LIMITED stock price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the authority of ASX. Market capitalisation: €237.2m. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
MAYNE PHARMA GROUP LIMITED is an Australian pharmaceutical company focused on the development and commercialization of generic medicines and health products. It is listed on the Australian Securities Exchange under the ticker XASX.